5 Results for "

Intedanib

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Intedanib" in MCE Product Catalog:

79
79 Cited Publications
Cat. No.: HY-50904
CAS No.: 656247-17-5
Synonyms: BIBF 1120; Intedanib
Target:  

PDGFR VEGFR FGFR

연구분야:  

Cancer

Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50s of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM, respectively.
loading...
    loading...
Cat. No.: HY-50904S2
CAS No.: 1624587-87-6
Synonyms: BIBF 1120-d8; Intedanib-d8
연구분야:  

Cancer

Nintedanib-d8 is deuterium labeled Nintedanib. Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50s of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM, respectively.
loading...
    loading...
Cat. No.: HY-50904S1
Synonyms: BIBF 1120-13C,d3; Intedanib-13C,d3
연구분야:  

Cancer

Nintedanib- 13C,d3 is the 13C- and deuterium labeled Nintedanib. Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50s of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM, respectively.
loading...
    loading...
Cat. No.: HY-50904R
CAS No.: 656247-17-5
Synonyms: BIBF 1120 (Standard); Intedanib (Standard)
연구분야:  

Cancer

Nintedanib (Standard) is the analytical standard of Nintedanib. This product is intended for research and analytical applications. Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50s of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM, respectively.
loading...
    loading...
Cat. No.: HY-50904S
CAS No.: 1624587-84-3
Synonyms: BIBF 1120-d3; Intedanib-d3
Target:  

PDGFR VEGFR FGFR

연구분야:  

Cancer

Nintedanib-d3 is the deuterium labeled Nintedanib. Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50s of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM, respectively.
loading...
    loading...